MDLN PE Ratio & Valuation, Is MDLN Overvalued

Historical Valuation

Medline Inc (MDLN) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Medline Inc (MDLN) is between -- to -- according to relative valuation method.

Relative Value

Fair Zone

-----

Current Price：42.73

Fair

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Medline Inc (MDLN) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Medline Inc (MDLN) has a current Price-to-Book (P/B) ratio of 42.33. Compared to its 3-year average P/B ratio of 41.76, the current P/B ratio is approximately 1.37% higher. Relative to its 5-year average P/B ratio of 41.76, the current P/B ratio is about 1.37% higher. Medline Inc (MDLN) has a Forward Free Cash Flow (FCF) yield of approximately 2.98%. Compared to its 3-year average FCF yield of 3.10%, the current FCF yield is approximately -3.69% lower. Relative to its 5-year average FCF yield of 3.10%, the current FCF yield is about -3.69% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for MDLN competitors is 4.98, providing a benchmark for relative valuation. Medline Inc Corp (MDLN.O) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of 14.78%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of MDLN increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of MDLN in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is MDLN currently overvalued or undervalued?

What is Medline Inc (MDLN) fair value?

MDLN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Medline Inc (MDLN) is between to according to relative valuation method.

How does MDLN's valuation metrics compare to the industry average?

The average P/S ratio for MDLN's competitors is 4.98, providing a benchmark for relative valuation. Medline Inc Corp (MDLN) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of 14.78%, this premium appears unsustainable.

What is the current P/B ratio for Medline Inc (MDLN) as of Mar 23 2026?

As of Mar 23 2026, Medline Inc (MDLN) has a P/B ratio of 42.33. This indicates that the market values MDLN at 42.33 times its book value.

What is the current FCF Yield for Medline Inc (MDLN) as of Mar 23 2026?

As of Mar 23 2026, Medline Inc (MDLN) has a FCF Yield of 2.98%. This means that for every dollar of Medline Inc's market capitalization, the company generates 2.98 cents in free cash flow.

What is the current Forward P/E ratio for Medline Inc (MDLN) as of Mar 23 2026?

As of Mar 23 2026, Medline Inc (MDLN) has a Forward P/E ratio of 0.00. This means the market is willing to pay $0.00 for every dollar of Medline Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Medline Inc (MDLN) as of Mar 23 2026?

As of Mar 23 2026, Medline Inc (MDLN) has a Forward P/S ratio of 0.00. This means the market is valuing MDLN at $0.00 for every dollar of expected revenue over the next 12 months.

MDLN Valuation